Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers

被引:0
|
作者
Mamoru Shibata
Kazuki Fujita
Eri Hoshino
Kazushi Minami
Kenzo Koizumi
Satoshi Okada
Fumihiko Sakai
机构
[1] Tokyo Dental College Ichikawa General Hospital,Department of Neurology
[2] Saitama International Headache Center,undefined
[3] Saitama Neuropsychiatric Institute,undefined
[4] Saitama International Headache Center,undefined
来源
BMC Neurology | / 24卷
关键词
Migraine; Calcitonin gene-related peptide (CGRP); Monoclonal antibody; Real world; Headache Impact Test-6 (HIT-6); Japanese;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers (vol 24, 323, 2024)
    Shibata, Mamoru
    Fujita, Kazuki
    Hoshino, Eri
    Minami, Kazushi
    Koizumi, Kenzo
    Okada, Satoshi
    Sakai, Fumihiko
    BMC NEUROLOGY, 2024, 24 (01)
  • [2] Real-world evidence of calcitonin gene-related peptide-targeted antibodies for migraine prevention in Japanese patients: a single-center prospective cohort study
    Shibata, M.
    Minami, K.
    Koizumi, K.
    Okada, S.
    HEADACHE, 2023, 63 : 160 - 160
  • [3] Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review
    Schuster, Nathaniel M.
    Rapoport, Alan M.
    CLINICAL NEUROPHARMACOLOGY, 2017, 40 (04) : 169 - 174
  • [4] Calcitonin gene-related peptide-targeted therapies are effective options for the prevention and treatment of migraine
    Nie, Tina
    DRUGS & THERAPY PERSPECTIVES, 2023, 39 (06) : 195 - 199
  • [5] Calcitonin gene-related peptide-targeted therapies are effective options for the prevention and treatment of migraine
    Tina Nie
    Drugs & Therapy Perspectives, 2023, 39 : 195 - 199
  • [6] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, O.
    Brady, L.
    Zagar, A.
    Robles, Y.
    Hoyt, M.
    Hall, J.
    HEADACHE, 2023, 63 : 184 - 184
  • [7] Adherence and Persistence of Calcitonin Gene-Related Peptide Monoclonal Antibodies in Patients with Migraine: A Real-World Study
    Varnado, Oralee
    Brady, Brenna
    Zagar, Anthony J.
    Robles, Yvonne
    Hoyt, Margaret
    Hall, Jerry
    NEUROLOGY, 2023, 100 (17)
  • [8] Comparison of Treatment Patterns in Patients with Migraine Initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A Retrospective Real-World US Study
    Varnado, Oralee J.
    Brady, Brenna L.
    Zagar, Anthony J.
    Robles, Yvonne P.
    Hoyt, Margaret
    PATIENT PREFERENCE AND ADHERENCE, 2024, 18 : 69 - 88
  • [9] Monoclonal Antibodies against Calcitonin Gene-Related Peptide for Migraine Prophylaxis: A Systematic Review of Real-World Data
    Pavelic, Antun R.
    Woeber, Christian
    Riederer, Franz
    Zebenholzer, Karin
    CELLS, 2023, 12 (01)
  • [10] Discontinuation and Switching Patterns in Patients with Migraine initiating Calcitonin Gene-Related Peptide Monoclonal Antibodies: A US Real-World Study
    Varnado, O.
    Brady, L. B.
    Zagar, A.
    Robles, Y.
    Hoyt, M.
    HEADACHE, 2023, 63 : 49 - 50